Zymeworks
company
Funding Round
Post-IPO Equity
Money Raised
$ 100M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion |
|---|
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jan 8, 2016 | Series A | $ 61.50M | Northleaf Capital Partners,BDC Healthcare Venture,etc. | Detail |
| Sep 6, 2012 | Series Unknown | $ 11M | Advanced Biotechnologies Venture Fund | Detail |
| Jan 13, 2015 | Series Unknown | $ 23.98M | Advanced Biotechnologies Venture Fund,CTI Life Sciences Fund,etc. | Detail |
| Jun 28, 2019 | Post-IPO Equity | $ 201.30M | Detail | |
| Sep 22, 2011 | Series Unknown | $ 8.10M | CTI Capital | Detail |
| Mar 3, 2008 | Angel | $ 1.30M | Detail | |
| Nov 6, 2019 | Post-IPO Equity | 0 | Amplitude Venture Capital,Business Development Bank of Canada | Detail |
| Jun 8, 2018 | Post-IPO Equity | $ 97.80M | Citigroup Global Markets Canada Inc,MTS Health Partners,etc. | Detail |
| Feb 27, 2015 | Series Unknown | $ 1.78M | Detail | |
| Jan 27, 2020 | Post-IPO Equity | $ 320.80M | Detail | |
| Jan 9, 2014 | Series Unknown | $ 15M | Eli Lilly | Detail |
| Jan 1, 2005 | Seed | 0 | WUTIF | Detail |
| Jun 29, 2009 | Series Unknown | $ 3.20M | CTI Capital | Detail |
| Apr 27, 2017 | IPO | $ 63.60M | Detail |
